Skip to main content
Clinical Trials/NCT03445936
NCT03445936Active, not recruitingNot Applicable

PRELOOP Trial: Synthetic Versus Biological Mesh for Prevention of Incisional Hernia After Loop-ileostomy Closure

University of Oulu4 sites in 1 country100 target enrollmentStarted: February 13, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
100
Locations
4
Primary Endpoint
Incisional hernia

Study Overview

Brief Summary

This study compares a synthetic mesh and biological implant in prevention of incisional hernia after loop-ileostomy closure.

Detailed Description

Incisional hernia after loop-ileostomy closure may be an underestimated problem. Research on both biological and synthetic mesh in this context is scarce and no randomized controlled trials comparing meshes exist.

The aim of this study is to compare Parietene Macro and Permacol in prevention of incisional site hernia after temporary loop-ileostomy reversal after anterior resection and TME for rectal cancer.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Outcomes Assessor)

Masking Description

Subject is blinded of the mesh used. Outcome at 10 month follow-up is assessed by surgeon who was not involved in the operation.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Anterior resection and TME with temporary loop-ileostomy for rectal carcinoma
  • •18 years or older
  • •Patient has a life expectancy of at least 12 months.
  • •Patient signs the Informed consent and agrees to attend all study visits

Exclusion Criteria

  • •Patient with a comorbid illness or condition that would precluded the use of surgery (ASA 4-5).
  • •Patients with concurrent or previous malignant tumors within 5 years before study enrollment
  • •Patients with T4b tumors which imposed a multi-organ resection
  • •Patient undergone emergency procedures
  • •Primary rectal surgery along with major concomitant procedures (e.g. hepatectomies, other intestinal resections).
  • •Metastatic disease with life expectancy of less than 12 months
  • •Pregnancy or suspected pregnancy

Arms & Interventions

Parietene Macro

Active Comparator

Parietene Macro is a macroporous synthetic mesh used in retro muscular sublay position to prevent incisional hernia after loop-ileostomy closure.

Intervention: Parietene Macro (Device)

Permacol

Active Comparator

Permacol is a acellular porcine dermal implant used in retro muscular sublay position to prevent incisional hernia after loop-ileostomy closure.

Intervention: Permacol (Device)

Outcomes

Primary Outcomes

Incisional hernia

Time Frame: 10 months

Incidence of incisional hernia

Surgical site infection

Time Frame: 30 days

The incidence of surgical site infections at 30 days follow up

Secondary Outcomes

  • Operative time(30 days)
  • Incidence of hernia(5 years)
  • Cost analysis(5 years)
  • Complications classified by Clavien-Dindo classification(30 days)
  • Re-operation rate(5 years)
  • Length of stay(30 days)
  • Quality of life measured by RAND-36 survey(5 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Elisa Mäkäräinen

MD

University of Oulu

Study Sites (4)

Loading locations...

Similar Trials